Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   ADCOCK INGRAM
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
ADCOCK INGRAM
Jun-14
DR. REDDYS LAB/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs4,656319-   
Low Rs3,788230-   
Sales per share (Unadj.) Rs1,481.494.9-  
Earnings per share (Unadj.) Rs270.7-23.9-  
Cash flow per share (Unadj.) Rs345.7-19.8-  
Dividends per share (Unadj.) Rs40.000-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs1,389.674.5-  
Shares outstanding (eoy) m166.53168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.82.9 98.5%   
Avg P/E ratio x15.6-11.5 -135.8%  
P/CF ratio (eoy) x12.2-13.9 -88.1%  
Price / Book Value ratio x3.03.7 82.4%  
Dividend payout %14.80-   
Avg Mkt Cap Rs m703,03946,340 1,517.1%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m46,4662,908 1,597.6%   
Avg. sales/employee Rs Th03,730.7-  
Avg. wages/employee Rs Th0677.5-  
Avg. net profit/employee Rs Th0-940.1-  
INCOME DATA
Net Sales Rs m246,69716,016 1,540.3%  
Other income Rs m10,555112 9,411.0%   
Total revenues Rs m257,25216,128 1,595.0%   
Gross profit Rs m63,860-2,775 -2,300.9%  
Depreciation Rs m12,502691 1,808.6%   
Interest Rs m1,428434 329.2%   
Profit before tax Rs m60,485-3,788 -1,596.6%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,412237 6,510.6%   
Profit after tax Rs m45,073-4,036 -1,116.9%  
Gross profit margin %25.9-17.3 -149.4%  
Effective tax rate %25.5-6.2 -407.8%   
Net profit margin %18.3-25.2 -72.5%  
BALANCE SHEET DATA
Current assets Rs m203,16111,730 1,731.9%   
Current liabilities Rs m85,7216,600 1,298.8%   
Net working cap to sales %47.632.0 148.6%  
Current ratio x2.41.8 133.3%  
Inventory Days Days79111 71.4%  
Debtors Days Days107124 86.5%  
Net fixed assets Rs m112,6386,838 1,647.3%   
Share capital Rs m83374 1,120.2%   
"Free" reserves Rs m230,5710-   
Net worth Rs m231,40412,571 1,840.8%   
Long term debt Rs m1,2784,418 28.9%   
Total assets Rs m315,79923,747 1,329.8%  
Interest coverage x43.4-7.7 -560.7%   
Debt to equity ratio x00.4 1.6%  
Sales to assets ratio x0.80.7 115.8%   
Return on assets %14.7-15.2 -97.1%  
Return on equity %19.5-32.1 -60.7%  
Return on capital %26.6-19.8 -134.3%  
Exports to sales %52.20-   
Imports to sales %16.80-   
Net fx Rs m87,3190-   
CASH FLOW
From Operations Rs m58,8751,367 4,306.6%  
From Investments Rs m-41,373-420 9,856.3%  
From Financial Activity Rs m-26,8614,009 -670.0%  
Net Cashflow Rs m-9,0734,957 -183.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare DR. REDDYS LAB With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare DR. REDDYS LAB With: ABBOTT INDIA  ELDER PHARMA  BAFNA PHARMA  HIKAL.  NECTAR LIFESCIENCE  



Today's Market

Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today Cipla Buys Ivia Beauty Brands | India's Green Power Push | Top Buzzing Stocks Today(Pre-Open)

Indian share markets Slipped further as the session progressed and ended the day weak.